| Medicare is set to release a list of 15 more prescription drugs selected for the next round of its drug pricing negotiations by Feb. 1 — and weight-loss drugs like Ozempic may top the list. Other possible candidates include the breast cancer drug Ibrance, the asthma treatment Trelegy and the diabetes drug Tradjenta. | 